Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 13, 2019
Vizient announces it will create a centralized item master tool for a supply chain innovation program envisioned by the Captis network of member hospitals and providers.
read more
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a De Novo approval by the FDA for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm, creating a new...
read more
Wednesday, November 16, 2022
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a strategic partnership with Vastrax, a full-service, vascular clinical research organization (CRO).
read more
Thursday, November 08, 2018
MMS Holdings announced that the company has successfully assisted Vivozon in achieving a Fast Track Designation from the FDA for VVZ-149, a non-opioid pain killer.
read more
Monday, December 14, 2020
ERS Genomics announced a non-exclusive license agreement granting Vivlion access to ERS Genomics’ CRISPR/Cas9 patent portfolio, to enhance Vivlion’s gene editing reagents and screening services.
read more
Vivli has collaborated with BlueMetal to build a data sharing platform for clinical trial research, powered by Microsoft Azure.
read more
Wednesday, December 04, 2019
Vivera Pharmaceuticals has signed an agreement with Parexel.
read more
Sunny Pharmtech Inc., a Taiwan-based API and finished-dose drug development company, and Vitruvias Therapeutics, a generic drug development company, have signed two additional agreements to co-develop and market two additional high-value generic ...
read more
Wednesday, February 13, 2019
Vitruvias has entered into a collaborative development agreement with Bright Future Pharmaceutical Lab to develop a portfolio of semi-solids to be marketed in the United States and China.
read more
Wednesday, August 14, 2019
VitaLink Research (VLR) has acquired West Palm Beach, FL-based Comprehensive Clinical Trials (CCT).
read more
VitaLink Research has adopted the fully-integrated eSource, eRegulatory and Clinical Trial Management System (CTMS) from Clinical Research IO (CRIO).
read more
VRI is helping direct collection and processing of blood plasma donations from recovered COVID-19 patients and developing technologies to detect and quantify virus-fighting antibodies.
read more
VistaGen Therapeutics announced receipt of a $5 million non-dilutive upfront license payment from EverInsight Therapeutics.
read more
Wednesday, January 22, 2020
Visikol has expanded its footprint in New Jersey by moving its headquarters to a 6,400 square-foot space in Hampton, NJ.
read more
Thursday, December 07, 2023
Visgenx, a biotechnology firm dedicated to advancing gene therapies for degenerative retinal diseases, has revealed an expansion of its partnership with Charles River Laboratories International, a contract development and manufacturing organization (...
read more